Keratoderma blennorrhagicum is a skin condition marked by thick, crusty, pustular patches that appear mainly on the soles of the feet and palms of the hands. It is not a standalone disease but rather the most characteristic skin manifestation of reactive arthritis, a form of inflammatory joint disease triggered by infection elsewhere in the body.1PubMed Central. A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report The lesions can look nearly identical to a form of psoriasis, which makes diagnosis tricky and treatment decisions complicated.
What It Looks Like
The hallmark of keratoderma blennorrhagicum is pustular hyperkeratosis, which in plain terms means raised, scaly, blister-like bumps surrounded by thickened, hardened skin. The lesions tend to start as small, clear or yellowish pustules that gradually merge and crust over, sometimes forming waxy, brownish plaques. They favor the soles of the feet, but the palms, toes, fingers, and occasionally the legs or trunk can also be affected. In severe cases, the patches can become painful enough to make walking difficult.
The appearance is so close to pustular psoriasis that even under a microscope, pathologists have struggled to tell the two apart. As far back as 1924, researchers were making detailed microscopic studies trying to distinguish keratoderma blennorrhagicum from pustular psoriasis, and the difficulty of that distinction has persisted ever since.2JAMA. Keratosis Blennorrhagica: A Brief Review and Report on the Effects of Hyperpyrexia in Its Treatment Today, most dermatologists and rheumatologists accept that the two conditions are histologically indistinguishable and that the clinical context, specifically whether the patient has reactive arthritis, is what separates them.
The Link to Reactive Arthritis
Keratoderma blennorrhagicum does not appear on its own. It occurs as part of reactive arthritis, an inflammatory condition that develops days to weeks after a bacterial infection, typically in the urogenital or gastrointestinal tract.3PubMed. Reiter’s syndrome: the classic triad and more Reactive arthritis was historically known as Reiter’s syndrome, named after a physician whose wartime conduct later prompted the medical community to abandon his name for socio-ethical reasons. The condition is now uniformly called reactive arthritis.4PubMed. Reactive arthritis: the convoluted history of Reiter’s disease
The classic presentation of reactive arthritis involves a triad of symptoms: joint inflammation (arthritis), eye inflammation (conjunctivitis), and urethritis. But the full clinical picture often extends well beyond those three. Skin involvement is common and can include keratoderma blennorrhagicum, circinate balanitis (painless lesions on the head of the penis), nail changes, and oral ulcers.5PubMed. Reiter’s syndrome: the classic triad and more Early clinical descriptions emphasized that the keratoderma is part of a defined syndrome that also includes non-ankylosing arthritis (meaning the joints do not fuse) and conjunctivitis.6JAMA Dermatology. Blennorrhagic Balanitiform Keratoderma: Report of Three Additional Cases, Including One of Buccal Involvement
Keratoderma blennorrhagicum can show up during the acute phase of reactive arthritis, when joints are swollen and inflamed, or it can emerge during a chronic phase months or even years later.7PubMed Central. A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report That delayed onset can catch patients and doctors off guard, especially if the initial infection has already resolved and the arthritis has quieted down.
What Triggers It
Because keratoderma blennorrhagicum is a feature of reactive arthritis, its triggers are the infections that set off reactive arthritis in the first place. These are broadly divided into two categories: sexually transmitted infections affecting the urogenital tract and foodborne or waterborne infections affecting the gut.
Among urogenital triggers, Chlamydia trachomatis stands out. The skin lesions of reactive arthritis are found predominantly in cases triggered by chlamydial infection rather than by gastrointestinal bacteria.8PubMed. Mucocutaneous abnormalities in Chlamydia trachomatis-induced reactive arthritis Older literature frequently associated the condition with gonorrhea specifically, noting that keratoderma blennorrhagicum usually occurred in men with a history of gonorrheal urethritis alongside arthritis.9JAMA Dermatology. Keratoderma Blennorrhagicum The name itself reflects this origin: “blennorrhagicum” derives from “blennorrhagia,” an old term for gonorrheal discharge.
On the gastrointestinal side, bacteria such as Salmonella, Shigella, Yersinia, and Campylobacter are well-recognized triggers of reactive arthritis. However, the skin manifestations seem to be less prominent following gut infections than following chlamydial ones. The reason is not fully worked out, but it likely has to do with how different bacteria interact with the immune system and which immune pathways they activate.
One point worth noting is that the bacteria themselves are not present in the skin lesions. Keratoderma blennorrhagicum is not an infection of the skin. It is an immune-mediated response: the body’s inflammatory machinery, activated by the original infection, misfires and attacks the skin. By the time the lesions appear, the triggering organism may already be cleared from the body or confined to its original site.
Who Gets It
Reactive arthritis, and by extension keratoderma blennorrhagicum, has historically been reported far more often in men than in women. Early case series described it as a condition that “usually occurs in men,” with female cases noted as exceptions.10JAMA Dermatology. Keratoderma Blennorrhagicum Part of this male predominance may reflect the strong association with urethritis, which is more clinically obvious in men. Some researchers suspect that reactive arthritis is underdiagnosed in women because urogenital chlamydial infections can be asymptomatic, making it harder to connect the dots between an infection that was never noticed and joint symptoms that appear weeks later.
The typical age range is young adults, roughly 20 to 40, which mirrors the demographics of sexually transmitted infections. That said, the condition is not exclusive to this group. A documented case involved a 14-year-old boy who developed classic keratoderma blennorrhagicum on the palms and soles along with reactive arthritis.11PubMed Central. Keratoderma blenorrhagica Adolescents can develop reactive arthritis after gastrointestinal infections just as adults can, and the skin features that come with it look the same.
Genetics plays a role in susceptibility. People who carry the HLA-B27 gene variant are significantly more likely to develop reactive arthritis after an appropriate triggering infection. HLA-B27 is a gene involved in how the immune system presents fragments of bacteria to other immune cells, and its presence seems to amplify the misdirected inflammatory response. Not everyone with reactive arthritis is HLA-B27 positive, however, and the gene is neither necessary nor sufficient to cause the disease.
Keratoderma Blennorrhagicum in HIV
People living with HIV can develop reactive arthritis and keratoderma blennorrhagicum, and some evidence suggests their skin involvement may be more severe and harder to treat. In a single-center study of HIV-positive patients with rheumatic complaints, keratoderma blennorrhagicum was identified in a small percentage of the group.12PubMed. Rheumatological Manifestations in HIV-Positive Patients: A Single-Center Study The overlap between HIV and reactive arthritis creates a clinical puzzle because some of the immune-suppressing drugs used to manage severe skin lesions can be risky in patients who already have a compromised immune system. Methotrexate, for instance, is commonly used for keratoderma blennorrhagicum but requires careful consideration in the setting of HIV, where the risks of further immunosuppression are substantial.
The relationship between HIV and reactive arthritis gained particular attention in the 1980s and 1990s, when clinicians in sub-Saharan Africa and elsewhere noticed a spike in reactive arthritis cases among HIV-positive patients. In some of these patients, the skin manifestations were among the first signs that something was wrong immunologically, prompting HIV testing. This underscores the value of recognizing keratoderma blennorrhagicum as a potential clinical signal, not just a cosmetic nuisance.
Why It Gets Confused with Psoriasis
The resemblance between keratoderma blennorrhagicum and pustular psoriasis is not superficial. Under the microscope, both conditions show similar patterns of skin-cell overgrowth, collections of immune cells (neutrophils) in the upper layers of the skin, and thickening of the outermost skin layer. Many dermatopathologists consider them histologically indistinguishable. This has led to a long-running debate about whether keratoderma blennorrhagicum is truly a separate entity or whether it is simply psoriasis triggered by infection.
The practical distinction comes down to the clinical story. If a patient has the lesions and also has reactive arthritis, the skin condition is called keratoderma blennorrhagicum. If the same lesions appear without any preceding infection or arthritis, the diagnosis is pustular psoriasis. The treatment for both is broadly similar, which somewhat reduces the stakes of misclassification, but the distinction matters for two reasons. First, a diagnosis of keratoderma blennorrhagicum should prompt investigation for an underlying infection that might need its own treatment. Second, the joint and eye involvement of reactive arthritis requires its own management, and recognizing the skin lesions as part of that syndrome helps ensure nothing is missed.
One reported case involved keratoderma blennorrhagicum-like lesions that were initially mistaken for contact dermatitis, a much more common and benign condition. The misdiagnosis delayed recognition of the underlying reactive arthritis. This kind of diagnostic error is a reminder that unusual-looking rashes on the palms and soles deserve a second look, especially in a patient with any joint or eye complaints.
Treatment Approaches
Treatment of keratoderma blennorrhagicum depends on how severe the lesions are and whether the underlying reactive arthritis is being managed. Mild cases may respond to topical treatments like strong corticosteroid creams or keratolytic agents (creams that help soften and remove the thickened skin). These are often combined with treatment directed at the arthritis itself.
For more severe or widespread lesions, systemic therapy is needed. Methotrexate is one of the most commonly used drugs and has shown effectiveness in both the skin and joint manifestations. In the reported adolescent case, systemic corticosteroids combined with methotrexate led to significant improvement in both the skin lesions and the arthritis over a period of weeks.13PubMed Central. Keratoderma blenorrhagica Sulfasalazine is another option sometimes used in reactive arthritis.
When conventional disease-modifying drugs fail, biologic therapies enter the picture. Drugs that target tumor necrosis factor (TNF), such as adalimumab, are sometimes tried, as are those targeting specific interleukins involved in the inflammatory cascade, such as secukinumab. However, not every patient responds to these. A recent case report described a patient with severe keratoderma blennorrhagicum whose lesions actually worsened on both adalimumab and secukinumab. Switching to tofacitinib, a drug that works by inhibiting a different part of the immune signaling pathway called JAK, produced remarkable improvement within 20 days.14PubMed Central. A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report This is a single case report, not a large trial, so it is too early to draw broad conclusions, but it suggests that JAK inhibitors may offer a useful alternative for patients who do not respond to standard biologics.
If the triggering infection is still active, particularly a chlamydial infection, antibiotic treatment is appropriate. Treating the underlying infection does not always clear the skin lesions, since the immune response driving the keratoderma can persist after the bacteria are gone. Still, eliminating the infectious trigger is considered a sensible first step and may reduce the overall inflammatory burden.
How Long It Lasts
Keratoderma blennorrhagicum generally follows the course of the underlying reactive arthritis. In many patients, reactive arthritis is self-limiting, meaning the joint inflammation and associated symptoms resolve over months without permanent damage. When that happens, the skin lesions typically clear as well, though they can take their own time to fade.
A smaller proportion of patients develop chronic reactive arthritis, where symptoms persist or recur for years. In these patients, keratoderma blennorrhagicum can become an ongoing problem, flaring periodically or smoldering at a low level.15PubMed Central. A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report Chronic cases are more likely to need sustained systemic treatment. The severity of the initial reactive arthritis episode does not always predict whether it will become chronic, which makes follow-up important even after the first flare resolves.
Nail Changes and Other Skin Findings
Keratoderma blennorrhagicum is the most dramatic skin manifestation of reactive arthritis, but it is far from the only one. Nail changes are common and can include thickening, ridging, yellowing, and lifting of the nail plate from the nail bed, a pattern that again overlaps heavily with psoriatic nail disease. Circinate balanitis, which presents as painless, shallow erosions on the glans penis, is another classic finding and may be easier to recognize than keratoderma blennorrhagicum because of its distinctive location. Oral ulcers, typically painless, can appear on the tongue or palate. Ulcerative vulvitis has been described in women, though it is less well-studied.16PubMed. Reiter’s syndrome: the classic triad and more
Early reports also noted buccal (inside-of-the-cheek) involvement alongside keratoderma blennorrhagicum, reinforcing the idea that the condition can affect mucous membranes as well as keratinized skin.17JAMA Dermatology. Blennorrhagic Balanitiform Keratoderma: Report of Three Additional Cases, Including One of Buccal Involvement When multiple mucocutaneous findings appear together with joint and eye symptoms, the clinical picture becomes much easier to recognize. The difficulty arises when the skin lesions appear in isolation or before the other features have declared themselves, which is when misdiagnosis is most likely.
Why the Name Persists
Medical naming conventions have shifted considerably since the condition was first described. “Keratoderma” literally translates to “horn skin,” referring to the thick, hardened quality of the lesions. “Blennorrhagicum” ties the condition to blennorrhagia, which was a catch-all term for mucous discharge, most often from gonorrhea. The name thus encodes an assumption baked into early 20th-century medicine: that the skin condition was specifically a consequence of gonorrheal infection.
We now know the picture is more complex. The condition can follow chlamydial infection, gut infections, and even HIV-related immune dysfunction. Despite this broader understanding, the original name has stuck, in part because there is no widely accepted replacement and in part because the name is so specific that it functions as an unambiguous clinical label. A dermatologist hearing “keratoderma blennorrhagicum” knows exactly what is being described, even if the etymological connection to gonorrhea is misleading. In a field that renamed Reiter’s syndrome to reactive arthritis on ethical grounds, the continued use of this archaic Latin compound is something of an anomaly, one that persists more from convention than from clinical logic.18PubMed. Reactive arthritis: the convoluted history of Reiter’s disease